Skip to content
★ Sign in to follow
CT

Charles Thomas Bernhardt III

CFO
AIM ImmunoTech Inc.
Total declarations
8
Company
1
▲ Purchases (2 ops.)
€96k
▼ Sales (1 ops.)
€42k

Latest filing published 16 Jun 2010 for AIM ImmunoTech Inc., €95k.

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+10.1%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 16 Jun 2010 · 5990 days ago · €95k
    -31.0%
    Entry US$29,703.20 · Close at T+365 US$20,484.97
  • Filed 08 Dec 2009 · 6180 days ago · €759
    -16.9%
    Entry US$30,215.32 · Close at T+365 US$25,094.08

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Charles Thomas Bernhardt III: trading record in brief

Charles Thomas Bernhardt III is a declared insider of AIM ImmunoTech Inc., with filings sourced from SEC (Form 4). Between 31 January 2009 and 15 June 2010, the trades on record add up to 8 filings.

In open-market terms, that means 2 purchases worth €96k on one side and 1 sale worth €42k on the other. The net balance comes to €54k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 5 share grants. So far in 2010, the count stands at 1 purchase and 1 sale.

Most recently, on 16 June 2010, the filings show an open-market purchase worth €95k in AIM ImmunoTech Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Charles Thomas Bernhardt III

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations8 total

8 of 8 declarations